At univariate logistic regression analysis, CD21low and MZ B cells percentage, IgA levels at diagnosis and the presence of consolidations in the lower fields of CT scan, were found to have the higher likelihood in GL-ILD treatment prediction. The gene discussed is CD79A; the disease is interstitial lung disease.